Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory Study
Clinical trial NCT03594682 · UNKNOWN
Trial details
- NCT number
- NCT03594682
- Sponsor
- Beijing Chest Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2019-07-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.